FCR001

· Talaris Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FCR001, covering 2023-03-03 to 2023-03-03. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation [Phase 3]

See pricing